CYPHERPUNK TECHNOLOGIES INC. Operating Leases, Rent Expense
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Operating Leases, Rent Expense of $105.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-08-13
- CYPHERPUNK TECHNOLOGIES INC. operating leases, rent expense for the quarter ending 2021-06-30 was $105.00K, a 26.06% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. operating leases, rent expense for the quarter ending 2021-03-31 was $105.00K.
- CYPHERPUNK TECHNOLOGIES INC. operating leases, rent expense for the quarter ending 2020-06-30 was $142.00K, a 32.06% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. operating leases, rent expense for the quarter ending 2019-12-31 was $208.00K, a 6.73% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. operating leases, rent expense for fiscal 2020 was $549.00K, a 34.41% decline from fiscal 2019.
- CYPHERPUNK TECHNOLOGIES INC. operating leases, rent expense for fiscal 2019 was $837.00K, a 21.30% increase from fiscal 2018.
- CYPHERPUNK TECHNOLOGIES INC. operating leases, rent expense for fiscal 2018 was $690.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2021-06-30 | $105.00K 10-Q · filed 2021-08-13 | $210.00K 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | $105.00K 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | $549.00K 10-K · filed 2021-03-12 | |||
| 2020-06-30 | $142.00K 10-Q · filed 2021-08-13 | $340.00K 10-Q · filed 2021-08-13 | ||
| 2019-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $419.00K derived: sum of 2 quarters · filed 2021-03-12 | $628.00K derived: sum of 3 quarters · filed 2021-03-12 | $837.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $211.00K 10-Q · filed 2019-11-14 | $420.00K derived: sum of 2 quarters · filed 2019-11-14 | $629.00K 10-Q · filed 2019-11-14 | $852.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-06-30 | $209.00K 10-Q · filed 2019-08-09 | $418.00K 10-Q · filed 2019-08-09 | $641.00K derived: sum of 3 quarters · filed 2020-03-16 | $816.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | $209.00K 10-Q · filed 2019-05-15 | $432.00K derived: sum of 2 quarters · filed 2020-03-16 | $607.00K derived: sum of 3 quarters · filed 2020-03-16 | $719.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $398.00K derived: sum of 2 quarters · filed 2020-03-16 | $510.00K derived: sum of 3 quarters · filed 2020-03-16 | $690.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $175.00K 10-Q · filed 2019-11-14 | $287.00K derived: sum of 2 quarters · filed 2019-11-14 | $467.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $112.00K 10-Q · filed 2019-08-09 | $292.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $180.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |